Potential COVID-19 Applications of Immunophotonics’ Leading Drug Candidate, IP-001, Being Researched at the University of Oklahoma

OU Daily at the University of Oklahoma recently published a story on research being conducted by Dr. Wei R. Chen on IP-001’s potential application as an immune-system booster that could be used in conjunction with a COVID-19 vaccine. The story is available here . Print

The release as fetched from its publisher. immunophotonics.com ↗